(Q28269116)

https://api.crossref.org/works/10.1038/NRUROL.2012.116

Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008

21 April 2017

1 reference

https://api.crossref.org/works/10.1038/NRUROL.2012.116

Wnt-11 promotes neuroendocrine-like differentiation, survival and migration of prostate cancer cells

21 April 2017

1 reference

https://api.crossref.org/works/10.1038/NRUROL.2012.116

Wnt/beta-catenin signaling in development and disease

21 April 2017

1 reference

https://api.crossref.org/works/10.1038/NRUROL.2012.116

Wnt/beta-catenin signaling: components, mechanisms, and diseases

21 April 2017

1 reference

https://api.crossref.org/works/10.1038/NRUROL.2012.116

Association of the APC gene product with beta-catenin

21 April 2017

1 reference

https://api.crossref.org/works/10.1038/NRUROL.2012.116

Association of the APC tumor suppressor protein with catenins

21 April 2017

1 reference

https://api.crossref.org/works/10.1038/NRUROL.2012.116

Functional interaction of beta-catenin with the transcription factor LEF-1

21 April 2017

1 reference

https://api.crossref.org/works/10.1038/NRUROL.2012.116

XTcf-3 transcription factor mediates beta-catenin-induced axis formation in Xenopus embryos

21 April 2017

1 reference

https://api.crossref.org/works/10.1038/NRUROL.2012.116

PTEN and GSK3beta: key regulators of progression to androgen-independent prostate cancer

21 April 2017

1 reference

https://api.crossref.org/works/10.1038/NRUROL.2012.116

Role that phosphorylation of GSK3 plays in insulin and Wnt signalling defined by knockin analysis

21 April 2017

1 reference

https://api.crossref.org/works/10.1038/NRUROL.2012.116

The selectivity of protein kinase inhibitors: a further update

21 April 2017

1 reference

https://api.crossref.org/works/10.1038/NRUROL.2012.116

Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer.

21 April 2017

1 reference

https://api.crossref.org/works/10.1038/NRUROL.2012.116

Autocrine WNT signaling contributes to breast cancer cell proliferation via the canonical WNT pathway and EGFR transactivation

21 April 2017

1 reference

https://api.crossref.org/works/10.1038/NRUROL.2012.116

Low-density lipoprotein receptor-related protein 5 (LRP5) mediates the prostate cancer-induced formation of new bone

21 April 2017

1 reference

https://api.crossref.org/works/10.1038/NRUROL.2012.116

Elevated level of Wnt5a protein in localized prostate cancer tissue is associated with better outcome

21 April 2017

1 reference

https://api.crossref.org/works/10.1038/NRUROL.2012.116

Functional epigenomics identifies genes frequently silenced in prostate cancer

21 April 2017

1 reference

https://api.crossref.org/works/10.1038/NRUROL.2012.116

Membranous expression of secreted frizzled-related protein 4 predicts for good prognosis in localized prostate cancer and inhibits PC3 cellular proliferation in vitro

21 April 2017

1 reference

https://api.crossref.org/works/10.1038/NRUROL.2012.116

A new secreted protein that binds to Wnt proteins and inhibits their activities

21 April 2017

1 reference

https://api.crossref.org/works/10.1038/NRUROL.2012.116

Secreted Frizzled-related protein-1 is a negative regulator of androgen receptor activity in prostate cancer

21 April 2017

1 reference

https://api.crossref.org/works/10.1038/NRUROL.2012.116

Secreted frizzled related protein 1 is a paracrine modulator of epithelial branching morphogenesis, proliferation, and secretory gene expression in the prostate

21 April 2017

1 reference

https://api.crossref.org/works/10.1038/NRUROL.2012.116

Identification of SFRP1 as a candidate mediator of stromal-to-epithelial signaling in prostate cancer

21 April 2017

1 reference

https://api.crossref.org/works/10.1038/NRUROL.2012.116

Linking beta-catenin to androgen-signaling pathway

21 April 2017

1 reference

https://api.crossref.org/works/10.1038/NRUROL.2012.116

Liganded androgen receptor interaction with beta-catenin: nuclear co-localization and modulation of transcriptional activity in neuronal cells

21 April 2017

1 reference

https://api.crossref.org/works/10.1038/NRUROL.2012.116

LEF1 in androgen-independent prostate cancer: regulation of androgen receptor expression, prostate cancer growth, and invasion

21 April 2017

1 reference

https://api.crossref.org/works/10.1038/NRUROL.2012.116

Recruitment of beta-catenin by wild-type or mutant androgen receptors correlates with ligand-stimulated growth of prostate cancer cells

21 April 2017

1 reference

https://api.crossref.org/works/10.1038/NRUROL.2012.116

A direct beta-catenin-independent interaction between androgen receptor and T cell factor 4

21 April 2017

1 reference

https://api.crossref.org/works/10.1038/NRUROL.2012.116

Structural basis of coactivation of liver receptor homolog-1 by -catenin

21 April 2017

1 reference

https://api.crossref.org/works/10.1038/NRUROL.2012.116

Functional localization and competition between the androgen receptor and T-cell factor for nuclear beta-catenin: a means for inhibition of the Tcf signaling axis

21 April 2017

1 reference

https://api.crossref.org/works/10.1038/NRUROL.2012.116

The beta-catenin binding protein ICAT modulates androgen receptor activity

21 April 2017

1 reference

https://api.crossref.org/works/10.1038/NRUROL.2012.116

Activated Wnt/beta-catenin signaling in melanoma is associated with decreased proliferation in patient tumors and a murine melanoma model

21 April 2017

1 reference

https://api.crossref.org/works/10.1038/NRUROL.2012.116

Activation of beta-catenin in prostate epithelium induces hyperplasias and squamous transdifferentiation

21 April 2017

1 reference

https://api.crossref.org/works/10.1038/NRUROL.2012.116

Inactivation of Apc in the mouse prostate causes prostate carcinoma

21 April 2017

1 reference

https://api.crossref.org/works/10.1038/NRUROL.2012.116

Activation of Wnt signaling by chemically induced dimerization of LRP5 disrupts cellular homeostasis

21 April 2017

1 reference

https://api.crossref.org/works/10.1038/NRUROL.2012.116

Tankyrase inhibition stabilizes axin and antagonizes Wnt signalling

21 April 2017

1 reference

https://api.crossref.org/works/10.1038/NRUROL.2012.116

An intrinsically labile α-helix abutting the BCL9-binding site of β-catenin is required for its inhibition by carnosic acid

21 April 2017

1 reference

https://api.crossref.org/works/10.1038/NRUROL.2012.116

Niclosamide suppresses cancer cell growth by inducing Wnt co-receptor LRP6 degradation and inhibiting the Wnt/β-catenin pathway

21 April 2017

1 reference

https://api.crossref.org/works/10.1038/NRUROL.2012.116

The role of Wnt5a in prostate gland development

21 April 2017

1 reference

https://api.crossref.org/works/10.1038/NRUROL.2012.116

WNT5A selectively inhibits mouse ventral prostate development

21 April 2017

1 reference

https://api.crossref.org/works/10.1038/NRUROL.2012.116

Cadherin cell adhesion receptors as a morphogenetic regulator

21 April 2017

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2012.116

Secreted antagonists of the Wnt signalling pathway

21 April 2017

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2012.116

Small molecule-mediated disruption of Wnt-dependent signaling in tissue regeneration and cancer

21 April 2017

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2012.116

Wnt signalling and its impact on development and cancer

21 April 2017

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2012.116

Design and end points of clinical trials for patients with progressive prostate cancer and castrate levels of testosterone: recommendations of the Prostate Cancer Clinical Trials Working Group

21 April 2017

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2012.116

Mechanisms underlying the development of androgen-independent prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2012.116

Noncanonical Wnt signaling mediates androgen-dependent tumor growth in a mouse model of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2012.116

Wnt3a growth factor induces androgen receptor-mediated transcription and enhances cell growth in human prostate cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2012.116

Analysis of Wnt gene expression in prostate cancer: mutual inhibition by WNT11 and the androgen receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2012.116

Wnt/Fz signaling and the cytoskeleton: potential roles in tumorigenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2012.116

Interplay of cadherin-mediated cell adhesion and canonical Wnt signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2012.116

Activation of β-catenin signaling in androgen receptor-negative prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2012.116

Mutations in the AXIN1 gene in advanced prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2012.116

Epigenetics in prostate cancer: biologic and clinical relevance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2012.116

In vitro evidence for complex modes of nuclear beta-catenin signaling during prostate growth and tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2012.116

Up-regulation of Wnt-1 and beta-catenin production in patients with advanced metastatic prostate carcinoma: potential pathogenetic and prognostic implications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2012.116

Lower levels of nuclear beta-catenin predict for a poorer prognosis in localized prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2012.116

Co-downregulation of cell adhesion proteins alpha- and beta-catenins, p120CTN, E-cadherin, and CD44 in prostatic adenocarcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2012.116

Decreased expression of catenins (alpha and beta), p120 CTN, and E-cadherin cell adhesion proteins and E-cadherin gene promoter methylation in prostatic adenocarcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2012.116

Alterations in beta-catenin expression and localization in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2012.116

Subjective differences in outcome are seen as a function of the immunohistochemical method used on a colorectal cancer tissue microarray

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2012.116

Modulation of cellular apoptotic potential: contributions to oncogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2012.116

Phosphatidylinositol 3-kinase/Akt stimulates androgen pathway through GSK3beta inhibition and nuclear beta-catenin accumulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2012.116

Tumor suppressor PTEN inhibits nuclear accumulation of beta-catenin and T cell/lymphoid enhancer factor 1-mediated transcriptional activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2012.116

Phosphatidylinositol 3-kinase signaling does not activate the wnt cascade

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2012.116

PTEN mutations do not cause nuclear beta-catenin accumulation in endometrial carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2012.116

β-Catenin activation synergizes with PTEN loss to cause bladder cancer formation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2012.116

Exploring the specificity of the PI3K family inhibitor LY294002.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2012.116

p53 and microRNA-34 are suppressors of canonical Wnt signaling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2012.116

FZD4 as a mediator of ERG oncogene-induced WNT signaling and epithelial-to-mesenchymal transition in human prostate cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2012.116

An autocrine mechanism for constitutive Wnt pathway activation in human cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2012.116

Expression profile of WNT molecules in prostate cancer and its regulation by aminobisphosphonates.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2012.116

Overexpression of fatty acid synthase is associated with palmitoylation of Wnt1 and cytoplasmic stabilization of beta-catenin in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2012.116

Targeting protein lipidation in disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2012.116

Wnt5a signaling is involved in the aggressiveness of prostate cancer and expression of metalloproteinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2012.116

The opposing roles of Wnt-5a in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2012.116

Wnt11 in 2011 - the regulation and function of a non-canonical Wnt.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2012.116

Prostate tumor progression is mediated by a paracrine TGF-beta/Wnt3a signaling axis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2012.116

Androgen-induced Wnt signaling in preosteoblasts promotes the growth of MDA-PCa-2b human prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2012.116

Function and biological roles of the Dickkopf family of Wnt modulators

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2012.116

Beyond Wnt inhibition: new functions of secreted Frizzled-related proteins in development and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2012.116

WIF1, a component of the Wnt pathway, is down‐regulated in prostate, breast, lung, and bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2012.116

The role of secreted frizzled-related protein 2 expression in prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2012.116

The Wnt inhibitory factor 1 restoration in prostate cancer cells was associated with reduced tumor growth, decreased capacity of cell migration and invasion and a reversal of epithelial to mesenchymal transition

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2012.116

Inhibition of Wnt signaling downregulates Akt activity and induces chemosensitivity in PTEN-mutated prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2012.116

Secreted frizzled-related protein 4 inhibits proliferation and metastatic potential in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2012.116

Dickkopf-1 expression increases early in prostate cancer development and decreases during progression from primary tumor to metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2012.116

Dickkopf-1 (DKK-1) stimulated prostate cancer growth and metastasis and inhibited bone formation in osteoblastic bone metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2012.116

p21CIP-1/WAF-1 induction is required to inhibit prostate cancer growth elicited by deficient expression of the Wnt inhibitor Dickkopf-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2012.116

Androgen receptor signaling in prostate cancer development and progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2012.116

Beta-catenin binds to the activation function 2 region of the androgen receptor and modulates the effects of the N-terminal domain and TIF2 on ligand-dependent transcription

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2012.116

Androgen regulation of the androgen receptor coregulators

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2012.116

The androgen receptor can promote beta-catenin nuclear translocation independently of adenomatous polyposis coli

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2012.116

Complex regulation of human androgen receptor expression by Wnt signaling in prostate cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2012.116

Cross-regulation of signaling pathways: an example of nuclear hormone receptors and the canonical Wnt pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2012.116

Interaction of nuclear receptors with the Wnt/beta-catenin/Tcf signaling axis: Wnt you like to know?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2012.116

Ligand-dependent inhibition of beta-catenin/TCF signaling by androgen receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2012.116

Interaction of beta-catenin and TIF2/GRIP1 in transcriptional activation by the androgen receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2012.116

Synergistic effects of coactivators GRIP1 and beta-catenin on gene activation: cross-talk between androgen receptor and Wnt signaling pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2012.116

Activation of beta-catenin signaling in prostate cancer by peptidyl-prolyl isomerase Pin1-mediated abrogation of the androgen receptor-beta-catenin interaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2012.116

Synergistic coactivator function by coactivator-associated arginine methyltransferase (CARM) 1 and beta-catenin with two different classes of DNA-binding transcriptional activators

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2012.116

Interaction and functional cooperation between the LIM protein FHL2, CBP/p300, and beta-catenin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2012.116

Glycogen synthase kinase-3beta activity is required for androgen-stimulated gene expression in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2012.116

Inhibition of glycogen synthase kinase-3 represses androgen receptor activity and prostate cancer cell growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2012.116

A re-evaluation of the "oncogenic" nature of Wnt/beta-catenin signaling in melanoma and other cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2012.116

Wnt/β-catenin signaling and AXIN1 regulate apoptosis triggered by inhibition of the mutant kinase BRAFV600E in human melanoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2012.116

Identification of aryl hydrocarbon receptor as a putative Wnt/beta-catenin pathway target gene in prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2012.116

WNT-3A modulates articular chondrocyte phenotype by activating both canonical and noncanonical pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2012.116

Crosstalk between the androgen receptor and beta-catenin in castrate-resistant prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2012.116

Stabilization of beta-catenin induces lesions reminiscent of prostatic intraepithelial neoplasia, but terminal squamous transdifferentiation of other secretory epithelia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2012.116

K-ras and Wnt signaling synergize to accelerate prostate tumorigenesis in the mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2012.116

Activation of beta-Catenin in mouse prostate causes HGPIN and continuous prostate growth after castration

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2012.116

Wnt/β-catenin activation promotes prostate tumor progression in a mouse model

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2012.116

Mining the Wnt pathway for cancer therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2012.116

Winning WNT: race to Wnt signaling inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2012.116

Identification of a specific inhibitor of the dishevelled PDZ domain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2012.116

Discovery and characterization of a small molecule inhibitor of the PDZ domain of dishevelled.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2012.116

Small-molecule inhibition of Wnt signaling through activation of casein kinase 1α

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2012.116

An RNAi-based chemical genetic screen identifies three small-molecule inhibitors of the Wnt/wingless signaling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2012.116

A diterpenoid derivative 15-oxospiramilactone inhibits Wnt/β-catenin signaling and colon cancer cell tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2012.116

Small-molecule antagonists of the oncogenic Tcf/beta-catenin protein complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2012.116

A useful approach to identify novel small-molecule inhibitors of Wnt-dependent transcription

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2012.116

A small molecule inhibitor of beta-catenin/CREB-binding protein transcription [corrected]

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2012.116

Suppression of Wnt/beta-catenin signaling inhibits prostate cancer cell proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2012.116

A novel dietary triterpene Lupeol induces fas-mediated apoptotic death of androgen-sensitive prostate cancer cells and inhibits tumor growth in a xenograft model

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2012.116

Lupeol inhibits proliferation of human prostate cancer cells by targeting beta-catenin signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2012.116

Lupeol, a novel androgen receptor inhibitor: implications in prostate cancer therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2012.116

Non-competitive androgen receptor inhibition in vitro and in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2012.116

The anti-helminthic niclosamide inhibits Wnt/Frizzled1 signaling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2012.116

Regulation of epithelial branching morphogenesis and cancer cell growth of the prostate by Wnt signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2012.116

Axin2 expression identifies progenitor cells in the murine prostate

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2012.116

Wnt signaling in stem and cancer stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2012.116

Bmi-1 is a crucial regulator of prostate stem cell self-renewal and malignant transformation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2012.116

Stem cells in prostate cancer: treating the root of the problem.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2012.116

WNT signaling regulates self-renewal and differentiation of prostate cancer cells with stem cell characteristics

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2012.116

Cell adhesion and signalling by cadherins and Ig-CAMs in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2012.116

APC/CTNNB1 (?-catenin) pathway alterations in human prostate cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2012.116

Detection and analysis of beta-catenin mutations in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2012.116

The Wnt antagonist DICKKOPF-1 gene is a downstream target of beta-catenin/TCF and is downregulated in human colon cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2012.116

Does GSK-3 provide a shortcut for PI3K activation of Wnt signalling?

31 March 2020

1 reference

12 December 2020

Caught up in a Wnt storm: Wnt signaling in cancer

1 reference

12 December 2020

1 reference

12 December 2020

Expression of beta-catenin in prostatic adenocarcinomas: a comparison with colorectal adenocarcinomas

1 reference

12 December 2020

Beta-catenin mutations in human prostate cancer.

1 reference

12 December 2020

Regulation of Wnt/beta-catenin signaling by protein kinases

1 reference

12 December 2020

Beta-catenin affects androgen receptor transcriptional activity and ligand specificity

1 reference

12 December 2020

A truncated beta-catenin disrupts the interaction between E-cadherin and alpha-catenin: a cause of loss of intercellular adhesiveness in human cancer cell lines

1 reference

12 December 2020